Pharmacotherapy of Child and Adolescent Psychiatric Disorders. 3rd Edition – Healthcare, Healthcare Services, Mental Health, Therapeutic Area Industries

The Pharmacotherapy of Child and Adolescent Psychiatric Disorders. 3rd Edition Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Mental Health, Therapeutic Area Markets.

This book fulfils an urgent need for an updated text on pediatric psychopharmacology. It takes a unique approach in discussing recent findings within the context of current issues, including economic and political ones. The book covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, e.g, schizophrenia or bipolar disorder, but who are deemed to be at high risk. This is an active area of debate: such children are being treated in certain centers, while others reject this completely. The book addresses the antidepressant controversy, the placebo response and unique strategies for delineating this, and ways to optimize the differential between active medication and placebo. It reviews the impact of recent American Heart Association guidelines for monitoring children on stimulants and other psychotropics. It adheres closely to DSM–IV diagnostic criteria throughout. The book describes the use of newly approved drugs such as Lexapro for treating adolescent depression and the novel compound Intuniv. It covers the TADS and CAMS studies, which evaluated the use of SSRIs alone and in combination with cognitive behavioral therapy for adolescent depression. Other topics include treatment of bipolar disorders, the increasing popularity of generic equivalents, combination pharmacotherapy and the potential dangers of psychotropic medications.

  • Third edition of the first ever book published on pediatric psychopharmacology from renowned editors.
  • Incorporates current developments with regard to SSRIs, their indications and their safety issues, including possible associated suicidal behavior.
  • Addresses concerns about cardiovascular side effects of the new stimulant medications available, and compares to other FDA–approved medications for ADHD.
  • Features many tables, figures and pictorials, making it highly accessible and reader friendly.

Read more and order at Pharmacotherapy of Child and Adolescent Psychiatric Disorders. 3rd Edition

Clinical Sports Psychiatry. An International Perspective. World Psychiatric Association – Healthcare, Healthcare Services, Mental Health, Therapeutic Area Industries

The Clinical Sports Psychiatry. An International Perspective. World Psychiatric Association Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Mental Health, Therapeutic Area Markets.

This book has it all – written by national and international experts and edited by world authorities, it is the first book on sport psychiatry in over a decade.  Dealing with psychopathology, mental health problems and clinical management, it differs markedly from sports psychology books that focus on performance issues.  Eating disorders, exercise addiction, drug abuse are all problems that are seen in everyday athletes, not just elite performers.  This book shows how to help. 

This text covers the most important topics in contemporary sports psychiatry/psychology from an international perspective. Chapter authors are experts in the field and global leaders in the related professional organizations, including current and past Presidents/Chairs of the International Society for Sports Psychiatry and of the World Psychiatric Association Section on Exercise and Sports Psychiatry.  Authors are mainly psychiatrists: the rest are PhD sport psychologists. 

The book comprises representative chapter authors from around the world, to an extent unprecedented in this topic.  The authors and editors are well–informed in global perspectives, e.g., having served as consultants to numerous Olympic teams, in addition to service on the International Society for Sports Psychiatry′s Board of Directors.

Specifically, this book covers four main categories of topics: 

1)      mental health challenges faced by athletes (including substance use disorders, exercise addiction, eating disorders, depression, suicide, and concussion),

2)      treatment approaches and therapeutic issues with athletes (including different types of psychotherapy for psychiatric disorders, psychotherapeutic performance enhancement approaches, transference and countertransference issues, achievement by proxy, psychotherapeutic issues as applied to a couple of sports that are played around the world, and use of psychiatric medications in athletes),

3)      psychosocial issues affecting athletes (including sexual harassment and abuse, cultural issues, and ethics issues), and

4)      the field of sports psychiatry (including work within one common sports psychiatry practice setting, and current status of and challenges in the field of sports psychiatry). 

There is a growing need for this book. Performance–enhancing drugs, use of psychotropics in impaired athletes, head trauma, sexual abuse, eating disorders, ethics, and depression and suicide in athletes, are just a few of the timely subjects addressed in this text. This is the only comprehensive reference available for those working in the field (or merely interested in it) to consult for current information on these topics. The existing sports psychology texts all focus on performance issues, with little, if any, attention paid to these areas of clinical significance. The book addresses the core differences between sports psychiatry and sports psychology, as well as the areas of overlap.  Emphasis is placed on how the disciplines should work together in diagnosing and treating athletes dealing with emotional stress and psychopathology.

Chapters include case examples and specific goals listed at the beginning, along with tables and graphs to highlight key concepts.

Read more and order at Clinical Sports Psychiatry. An International Perspective. World Psychiatric Association

Proven Programs to Help Reduce Health Care Costs Related to: Diabetes, High Blood Pressure, and Heart Disease – Webinar – Healthcare, Healthcare Services, Hematology, Therapeutic Area Industries

The Proven Programs to Help Reduce Health Care Costs Related to: Diabetes, High Blood Pressure, and Heart Disease – Webinar Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Hematology, Therapeutic Area Markets.

In the United States alone there are over 86 million people who suffer with pre-diabetes and over 29 million who are diagnosed with diabetes. The cost analysis in healthcare is estimated at over 245 billion dollars, 69 billion of that is related to productivity. Not to mention work related issues which result from; low blood sugar, high blood sugar, inappropriate timing of medications and meals that can lead to injuries at work and the risk of secondary complications.

In addition, High Blood Pressure and Heart Disease also present with significant issues in the workplace wellness programs. Couple these issues with the healthcare costs which skyrocket when these issues are not managed properly can have a major impact on your organization and its employee wellness programs. Marlisa Brown has over 20 years’ experience working on solutions to all these disorders where she treated over 15,000 patients and worked with hundreds of corporations. Marlisa will help you to identify ways to implement wellness programs that will give results. Her tried and true programs will give you what you need to start immediately giving you measurable results within as little as a 3-4 month period. Also, she will provide you with tools to use in emergency situations if these disorders lead to an incident at the workplace.

Programs presented will be easy to utilize in a safe appropriate manner. Also some of the programs can be started almost immediately and will provide simple evaluation tools that will indicate the success of each intervention. Education of the risk factors associated with diabetes, hypertension and cardiac disorders will be covered as well identification of why they contribute to work related issues. In addition, simple solutions and strategies will be presented to help better prepare and protect against future incidents.

Read more and order at Proven Programs to Help Reduce Health Care Costs Related to: Diabetes, High Blood Pressure, and Heart Disease – Webinar

France Interventional Cardiology Procedures Outlook to 2021 – Cardiology, Healthcare, Healthcare Services, Therapeutic Area Industries

The France Interventional Cardiology Procedures Outlook to 2021 Report has been published. It provides updated in 2018 year analysis of industries from Cardiology, Healthcare, Healthcare Services, Therapeutic Area Markets.

France Interventional Cardiology Procedures Outlook to 2021

Summary

Our new report, "France Interventional Cardiology Procedures Outlook to 2021", provides key procedures data on the France Interventional Cardiology Procedures. The report provides procedure volumes within market segments – Angiography Procedures, Balloon Angioplasty Procedures, Coronary Stenting Procedures, PTCA Drug Eluting Balloon (DEB) Angioplasty Procedures and Percutaneous Coronary Intervention (PCI) Procedures.

The data in the report is derived from dynamic market forecast models. We use epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

– France Interventional Cardiology Procedures volumes by segments – Angiography Procedures, Balloon Angioplasty Procedures, Coronary Stenting Procedures, PTCA Drug Eluting Balloon (DEB) Angioplasty Procedures and Percutaneous Coronary Intervention (PCI) Procedures.
– Projections for each of the market segments. Data is provided from 2007 to 2014 and forecast to 2021.

Reasons to buy

– Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
– Develop market-entry and market expansion strategies.

Read more and order at France Interventional Cardiology Procedures Outlook to 2021

Argentina Contraceptive Devices Market – Growth, Trends, and Forecasts 2017 – 2022 – Healthcare, Healthcare Services, Therapeutic Area, Women’s Health Industries

The Argentina Contraceptive Devices Market – Growth, Trends, and Forecasts 2017 – 2022 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Therapeutic Area, Women’s Health Markets.

Argentina’s market for contraceptive devices was estimated at USD 0.160 billion in the year 2014 and is expected to grow at a CAGR of 7.79% from 2014 to 2019.

Geographically, North America is the largest market in terms of contraceptive usage, followed by Europe. The emerging nations lack the proper awareness about the potential benefits of contraceptive usage. However, this trend is changing in regions like Africa, Asia-Pacific, and Latin America. The market is set to boom in these regions over the next few years.

This escalation is developing the need to analyze, review and forecast the growth of the contraceptive devices market. Owing to the rapid evolution of the market in the use of intrauterine devices, medical device companies that are able to launch new innovative equipment will be rewarded with huge benefits.

Argentina Contraceptive Devices Market-Market Dynamics

The report details several factors driving and restraining the market, some of which are listed below.

Drivers

Need to avoid unwanted pregnancies and their complications
Increasing incidences of STDs
Rapid population rise globally
Potential non-contraception health benefits
Government initiatives
Restraints

Religious and cultural oppositions in certain sectors of the society
Fear of side-effects and infertility
Lack of awareness
Limited access in developing economies
The market is segmented by contraceptive devices, which include condoms, diaphragms, cervical caps, sponges, vaginal rings, IUDs, and implants. Contraceptive methods are also studied in detail, which include sterilization, pills, implants, injectables, intrauterine devices, male condoms and vaginal barrier methods.

Key Deliverables:

Market analysis for Argentina’s contraceptive devices market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market.
Identification and analysis of the macro and micro factors that affect Argentina’s contraceptive devices market.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is growing and to also identify the regions that are still untapped.

Read more and order at Argentina Contraceptive Devices Market – Growth, Trends, and Forecasts 2017 – 2022

Primary Care ENT, An Issue of Primary Care: Clinics in Office Practice. The Clinics: Internal Medicine 41-1 – Healthcare, Healthcare Services, Therapeutic Area Industries

The Primary Care ENT, An Issue of Primary Care: Clinics in Office Practice. The Clinics: Internal Medicine 41-1 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Therapeutic Area Markets.

This issue of Primary Care: Clinics in Office Practice, edited by Gretchen Dickson, MD and Rick Kellerman, MD, is devoted to Primary Care ENT. Articles in this issue include Otitis Externa; Disease of the Internal Ear; Hearing Loss; Dizziness and Vertigo; Rhinitis; Sinusitis; Epistaxis; Laryngitis; Pharyngitis; Mouth Disease; and Neurological Syndromes pertaining to the Head and Neck.

Read more and order at Primary Care ENT, An Issue of Primary Care: Clinics in Office Practice. The Clinics: Internal Medicine 41-1

The Hand. Fundamentals of Therapy. Edition No. 3 – Healthcare, Healthcare Services, Sports Medicine and Physiotherapy, Therapeutic Area Industries

The The Hand. Fundamentals of Therapy. Edition No. 3 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Sports Medicine and Physiotherapy, Therapeutic Area Markets.

Completely revised, much of the existing text has been replaced and updated. There are four new chapters covering simple wrist fractures, nerve compression, tendon entrapment and free tissue transfers. Many of the illustrations have been updated with new pictures added to illustrate the new chapters.

Welcomed by both doctors and therapists intending to specialize in the subject, or those who regularly encounter hand patients in the course of general practice, this text is an accessible, quick reference book for all those involved in this difficult area of rehabilitation.

With its new content and attractive new format, the popularity of this book is assured.

Read more and order at The Hand. Fundamentals of Therapy. Edition No. 3

Global and Chinese Intra-uterine suction curette Industry – 2016 – Healthcare, Healthcare Services, Therapeutic Area, Women’s Health Industries

The Global and Chinese Intra-uterine suction curette Industry – 2016 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Therapeutic Area, Women’s Health Markets.

The 'Global and Chinese Intra-uterine suction curette Industry, – 2016' is a professional and in-depth study on the current state of the global Intra-uterine suction curette industry with a focus on the Chinese market. The report provides key statistics on the market status of the Intra-uterine suction curette manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2011-2016 market shares for each company.

Through the statistical analysis, the report depicts the global and Chinese total market of Intra-uterine suction curette industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2016-2021 market development trends of Intra-uterine suction curette industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.

In the end, the report makes some important proposals for a new project of Intra-uterine suction curette Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2011-2021 global and Chinese Intra-uterine suction curette industry covering all important parameters.

PLEASE NOTE: This report will be completed after order and will take approximately 2-3 business days after the confirmation of payment.

Read more and order at Global and Chinese Intra-uterine suction curette Industry – 2016

Critical Care Intravenous Infusion Drug Handbook. Edition No. 3 – Healthcare, Healthcare Services, Intensive Care and Emergency Medicine, Therapeutic Area Industries

The Critical Care Intravenous Infusion Drug Handbook. Edition No. 3 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Intensive Care and Emergency Medicine, Therapeutic Area Markets.

Compact and easy to use, this handy reference focuses on the information you need to administer intravenous medications in critical care and emergency environments. Essential coverage of 48 of the most common and complex IV drugs, including drip rate calculation charts, drug calculation formulae, and much more help you safely and efficiently administer IV drugs.

Read more and order at Critical Care Intravenous Infusion Drug Handbook. Edition No. 3

Psychiatric Hospitals in Australia – Industry Market Research Report – Healthcare, Healthcare Services, Mental Health, Therapeutic Area Industries

The Psychiatric Hospitals in Australia – Industry Market Research Report Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Mental Health, Therapeutic Area Markets.

Psychiatric Hospitals in Australia

The industry consists of psychiatric hospitals primarily providing specialist treatment for patients with psychiatric, mental or behavioural disorders.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

Read more and order at Psychiatric Hospitals in Australia – Industry Market Research Report